BEMS statutes

Attached are the French and Dutch versions of the current statutes. A new version is being worked on and will soon be published.

BEMS history

The European Environmental Mutagen Society (EEMS) was founded in 1970 by the late professor Frits H Sobels as an organization that promotes both fundamental and applied research in the fields of environmental mutagenesis and genetic toxicology.
 
The foundation of the Society was the result of discussions between a small group of geneticists and toxicologists who were seriously concerned about possible long-term adverse biological effects of chemicals in the human environment.
 
The main goal of the new Society was to study and evaluate potential genetic and carcinogenic hazards to man due to exposure to the increasing number and variety of chemicals in our environment. The European society is organized as an umbrella covering local european societies (per country) and associated with other international societies aiming at the same objectives within the International Associations for Environmental Mutagen Societies (IAEMS).
 
Some Belgian scientists attended regularly the meetings of the EEMS from the beginning, in particular the team of Professor Moutschen (Université de Liège). It is at one of these meetings (Edinburgh 1977) that Dr. Degraeve from the Liège group contacted me and suggested that also Belgium should have a national section and society. He put all his efforts in the creation and development of the BEMS. These efforts received a maximal support from professor Frits H Sobels and were very successful. Many laboratories and industries joined the BEMS, co-organized annual meetings, sponsored the society and the workshops. Special sessions and grants were organized to encourage young scientists. Moreover 2 european EEMS meetings took place in Belgium, one at the Vrije Universiteit Brussel in 1986 and one the University of Ghent in 2001. Members of the BEMS had a significant contribution at the international level as delegates to the EEMS council, secretary of EEMS (Marlies De Boeck), president of EEMS and vice-president of IAEMS (Micheline Kirsch-Volders). This would never have been possible without a dynamic and friendly collaboration among all the members of the BEMS.

Advanced Course Reproductive Toxicity – program and itinerary

Toxicity to embryo-fetal development

13 October 2011, Elewijt Center, Elewijt Belgium


8.30-9.00
 
Reception and coffee
 
 
9.00-10.30
 
Embryology (organogenesis)
 
Dr. Steven van Cruchten
 
10.30-10.35
 
Coffee
 
 
10.45-11.30
 
Regulatory (Guidelines, methods, parameters)
 
Dr. Koen Van Deun
 
11.30-13.00
 
Technical aspects & Pathology (skeleton and tissue observations)
 
Graham Bailey
Peter Delille
Sandra De Jonghe
 
13.00-14.00
 
Lunch
 
 
14.00-14.45
 
Interpretation and link to human risk assessment
 
Dr. Marie-Louise Meisters
Dr. Frank Schnoeder
 
14.45-17.00
 
Case study (Coffee available throughout the afternoon)
 
 
14.45-15.00
15.00-16.30

16.30-17.00

Introduction
Groups of 4 participants: working on dossier trying to answer questions listed
Overviewing the answers with the different groups plus the answers we prepared
 
17.00-17.15
 
Adjournments
 
 

You can download the preliminary program and itinerary to the Elewijt Center with the attachments below.

BEMS Meeting 2012: Itinerary and accommodation

Please take into account that you will need to check-in with security at the reception desk, you therefore need to arrive 15 minutes before the start of the event.

VENUE

JANSSEN PHARMACEUTICA
Auditorium at the Campus
Turnhoutseweg 30
B-2340 Beerse, Belgium

 

ITINERARY

Below, please find the directions to the Janssen facilities in Beerse. Upon arrival, please announce yourself at the reception desk. They will explain you where to park and how to get to the auditorium. Please take into account that this procedure may take about 10 minutes.
 
By car: On the E34 (A21) motorway, take exit 22 (Gierle/Beerse). Follow the signs to Beerse. At the second traffic lights, turn right. The main entrance of Janssen Pharmaceutica is about 500 m further, on the right-hand side. Park your car on the visitors’ parking, right to the main entrance.

By train: Take a train to Turnhout. Take bus 416 or 417 to Antwerp or 431 to Oostmalle. After about 10 minutes, take the stop at BEERSE HEIBERGSTRAAT. The main entrance of Janssen Pharmaceutica is just across the street.
Train info: www.belgianrail.be
Bus info: www.delijn.be
 
For further info on the venue, please contact Jacky Van Gompel:
jvgompel@its.jnj.com      
+32 14 60 5018
 
ACCOMMODATION
 
Hotels nearest to Janssen Pharmaceutica are all located in the center of Turnhout:

1st Annual Workshop on Non-Clinical Safety Assessment of Biopharmaceuticals

Wednesday 26 October 2011 – Janssen Pharmaceutica, Beerse, Belgium
Program

 

You can download this program from the pdf in attachment at the bottom of this page.

8:30-9:00
 
Coffee
 
 
9:00-9:05
 
Welcome
 
Mark Martens,
President of BelTox
 
Morning session 1: Introductory lectures
(chair : J. Baumeister -Ablynx & M. Cornet – UCB Pharma)

9:05-10:05
 
Safety assessment of biologics : specific requirements
for vaccines and antibodies
 
R. Foster,
CiToxLAB, F
 
10:05-11:05
 
Safety assessment of biologics : regulatory perspectives

 

J.W. van der Laan,
RIVM, Nl
 
11:05-11:25 Coffee break
 

Morning session 2: Non-clinical safety evaluation of vaccines
(chair : L. Segal – GSK Biologicals)


11:25-12:05
 
Prophylactic vaccine toxicology case study

 

S. Gould
Sanofi-Pasteur, F
 
12:05-12:45
 
Vaccine adjuvants safety evaluation

 

N. Garçon,
GSK Biologicals, B
 
12:45-13:45
 
Lunch and networking
 
 
Afternoon session: Non-clinical safety evaluation of antibodies and nanobodies
(chair : G. Bailey & I. Smyej – Johnson & Johnson)

13:45-14:25
 
Challenges in developmental and reproductive toxicity testing of biopharmaceuticals
 
G. Weinbauer,
Covance, D
 
14:25-14:55 Choice of species for reproductive toxicity studies with biopharmaceuticals A. Cauvin,
UCB Pharma, B
 
14:55-15:15
 
Coffee break
 
 
15:15-15:55
 
Immunogenicity testing in support of nonclinical
studies of biotherapeutics: experiences and challenges
 
M.P. Bouche,
Ablynx, B
 
15:55-16:35
 
Safety assessment of monoclonal antibodies : Specific requirements for infectious diseases

 

T.Kwaks,
Crucell, Nl
16:35-17:25
 
Safety assessment of Nanobodies : experienes and outlook

 

S. Jacobs,
Ablynx, B
 
17:25-17:35
 
Concluding remarks

 

M. Cornet, Beltox &
chair of the Organising Committee
17:35-19:00
 
Reception and networking

 

 
Organising Committee : Judith Baumeister (Ablynx), Annick Cauvin (UCB Pharma),
Miranda Cornet (UCB Pharma),
Ilham Smyej (Johnson & Johnson), Lawrence Segal (GSK Biologicals)
with the technical assistance of Marleen Hallam (BelTox) and Karin Van Tulden (Johnson & Johnson)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Program Introductory course 2011

 
Seminar:
Introduction to Toxicology and Ecotoxicology
as the Scientific Basis for Management
of Chemical Risk

 
Elewijt, 11 May, 2011
8.30-9.00
Reception and coffee
9.00-9.10
Part 1: Introduction to the seminar
Marie-Noëlle Blaude
9.10-9.40
Part 2: Introduction to toxicology
Koen Van Deun
9.40-10.20
Part 3: Analysis of cases involving toxic substances
Dominique Lison
10.20-10.40 Coffee
10.40-11.30
Part 4: Introduction to epidemiology Tim Nawrot

11.30-12.30

     11.30-12.00
     12.00-12.30

Part 5: Health risk assessment

    5.1 – Hazard assessment
    5.2 – Exposure assessment

 

Walter Janssens
Peter Hoet

12.30-13.45
Lunch with lecturers

 

13.45-14.15

Part 5 (cont'd): Health risk assessment

    5.3 – Risk assessment

 

Mark Martens

14.15-15.25
Part 6: Environmental risk assessment
     6.1 – Introduction to ecotoxicology
     6.2 – Risk assessment
Francesca Tencalla
15.25-15.45
Coffee  
15.45-16.50           15.45-16.20
16.20-16.40

Part 7: Hazard and risk communication
   7.1 – Labelling of chemical products
   7.2 – Risk assessment
 
Marie-Noëlle Blaude
Jacques de Gerlache
16.40-17.00
Panel discussion with all lecturers and feedback

All

You can download a copy of this program as well as the directions to the Elewijt Center from the attachments below.

10/09/2010: Introduction to Toxicology and Ecotoxicology as the Scientific Basis for Management of Chemical Risk

The BelTox course Introduction to Toxicology and Ecotoxicology took place in the Elewijt Conference Center on September 10th, 2010.  This one-day course organized for the 4th time was attended by 41 participants coming from industry (46%), European federations (20%), authorities (12%), institutions (12%) or others (10%).  The global overview of the many aspects of toxicology, even understandable for non-experts, was greatly appreciated.  Two thirds of the participants declared to be interested in a more detailed course.
The experts contributing to this course were coming from academia (Prof.Lison, Prof. Hoet and Prof. Nawrot), toxicology consulting (Dr Van Deun and Dr Tencalla), industry (Dr de Gerlache and Dr Martens)  and the Scientific Institute of Public Health (Dr Blaude).
We leave the last word about the negative feedback to one of the participants: "Even after hurting my brain… I can not find a negative comment for this course."

19-22/10/2011, Primošten, Croatia, International Mycology and Mycotoxicology Symposium

The Croatian Microbiology Society is organizing an International Mycology and Mycotoxicology Symposium to take place in Primošten, Croatia from 19 to 22, October 2011. The symposium will cover current topics in mycology and mycotoxicology with the aim to bring together scientists from many different disciplines, including applied and clinical mycology and mycotoxicology.
For more information, go to www.hmd-cms.hr.